BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29095152)

  • 1. Structure of the staphylococcal enterotoxin B vaccine candidate S19 showing eliminated superantigen activity.
    Jeong WH; Song DH; Hur GH; Jeong ST
    Acta Crystallogr F Struct Biol Commun; 2017 Nov; 73(Pt 11):595-600. PubMed ID: 29095152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
    Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
    Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
    Papageorgiou AC; Tranter HS; Acharya KR
    J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B.
    Li H; Llera A; Tsuchiya D; Leder L; Ysern X; Schlievert PM; Karjalainen K; Mariuzza RA
    Immunity; 1998 Dec; 9(6):807-16. PubMed ID: 9881971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
    Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
    Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
    Hamad AR; Herman A; Marrack P; Kappler JW
    J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the superantigen staphylococcal enterotoxin type A.
    Schad EM; Zaitseva I; Zaitsev VN; Dohlsten M; Kalland T; Schlievert PM; Ohlendorf DH; Svensson LA
    EMBO J; 1995 Jul; 14(14):3292-301. PubMed ID: 7628431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.
    Krupka HI; Segelke BW; Ulrich RG; Ringhofer S; Knapp M; Rupp B
    Protein Sci; 2002 Mar; 11(3):642-51. PubMed ID: 11847286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
    Woody MA; Krakauer T; Ulrich RG; Stiles BG
    J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of receptor mimics that inhibit superantigen pathogenesis.
    Möllhoff M; Zanden HB; Shiflett PR; Gupta G
    J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations affecting the superantigen activity of staphylococcal enterotoxin B.
    Briggs C; Garcia C; Zhang L; Guan L; Gabriel JL; Rogers TJ
    Immunology; 1997 Feb; 90(2):169-75. PubMed ID: 9135543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the superantigen staphylococcal enterotoxin B in complex with TCR and peptide-MHC demonstrates absence of TCR-peptide contacts.
    Rödström KE; Elbing K; Lindkvist-Petersson K
    J Immunol; 2014 Aug; 193(4):1998-2004. PubMed ID: 25015819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
    Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
    Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
    Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
    Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.
    Dutta K; Varshney AK; Franklin MC; Goger M; Wang X; Fries BC
    J Biol Chem; 2015 Mar; 290(11):6715-30. PubMed ID: 25572397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The domain structure and functional relationships in the bacterial superantigen, SEB.
    Hayball JD; O'Hehir RE; Lamb JR; Lake RA
    Biol Chem Hoppe Seyler; 1995 May; 376(5):303-9. PubMed ID: 7662172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the putative T-cell receptor cavity of the superantigen staphylococcal enterotoxin B.
    Garcia C; Briggs C; Zhang L; Guan L; Gabriel JL; Rogers TJ
    Immunology; 1998 Jun; 94(2):160-6. PubMed ID: 9741336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.